Richmond University Medical Center
- Type
- Teaching hospital
- Where
- Staten Island, NY
- Medicare CCN
- 330028
- Received
- $91,847 in 16 records, 2025 ($7,801 general, $84,046 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: RICHMOND UNIVERSITY MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: RICHMOND UNIVERSITY MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: RICHMOND UNIVERSITY MEDICAL CENTER Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 8 | $7,801 |
| 2025 | Research payment | 8 | $84,046 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Eli Lilly and Company | 2 | $48,737 | 2025 |
| GENZYME CORPORATION | 1 | $16,780 | 2025 |
| Eli Lilly Export S.A. Puerto Rico Branch | 2 | $8,383 | 2025 |
| Amgen Inc. | 2 | $6,273 | 2025 |
| Janssen Research & Development, LLC | 1 | $3,873 | 2025 |
| Medtronic, Inc. | 1 | $3,700 | 2025 |
| Medical Device Business Services, Inc. | 2 | $1,990 | 2025 |
| Scientia Vascular | 1 | $1,300 | 2025 |
| Olympus America Inc. | 1 | $476 | 2025 |
| Stryker Corporation | 2 | $295 | 2025 |
| BIOTRONIK INC. | 1 | $39 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 8 | $84,046 |
| Charitable Contribution | 1 | $3,700 |
| Grant | 2 | $1,990 |
| Gift | 1 | $1,300 |
| Debt forgiveness | 3 | $600 |
| Long term medical supply or device loan | 1 | $210 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | Scientia Vascular | $1,300 | Gift | In-kind items and services | Colossus Device, Neuro | 2025 | |
| 2025-12-31 | Stryker Corporation | $210 | Long term medical supply or device loan | In-kind items and services | TITAN Device, EMS | 2025 | |
| 2025-12-31 | Stryker Corporation | $84 | Debt forgiveness | Cash or cash equivalent | 2025 | ||
| 2025-10-22 | Medtronic, Inc. | $3,700 | Charitable Contribution | Cash or cash equivalent | 2025 | ||
| 2025-08-28 | GENZYME CORPORATION | $16,780 | Research payment | Cash or cash equivalent | WAYRILZ Drug, Immunology | A 52-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group, group sequential, phase 3 study to | 2025 |
| 2025-08-05 | Medical Device Business Services, Inc. | $995 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-08-05 | Medical Device Business Services, Inc. | $995 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-07-23 | Amgen Inc. | $3,897 | Research payment | In-kind items and services | A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Maridebart Cafraglut | 2025 | |
| 2025-07-15 | Eli Lilly and Company | $46,008 | Research payment | Cash or cash equivalent | A PARALLEL-GROUP TREATMENT, PHASE 2, DOUBLE-BLIND STUDY OF ONCE-WEEKLY SUBCUTANEOUS LY3457263 COMPARED TO PLACEBO IN PAR | 2025 | |
| 2025-06-26 | Amgen Inc. | $2,375 | Research payment | Cash or cash equivalent | A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Maridebart Cafraglut | 2025 | |
| 2025-05-30 | Olympus America Inc. | $476 | Debt forgiveness | In-kind items and services | 2025 | ||
| 2025-04-30 | BIOTRONIK INC. | $39 | Debt forgiveness | Cash or cash equivalent | 2025 | ||
| 2025-04-16 | Janssen Research & Development, LLC | $3,873 | Research payment | Cash or cash equivalent | JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC | 2025 | |
| 2025-04-03 | Eli Lilly Export S.A. Puerto Rico Branch | $7,918 | Research payment | In-kind items and services | A PARALLEL-GROUP TREATMENT, PHASE 2, DOUBLE-BLIND STUDY OF ONCE-WEEKLY SUBCUTANEOUS LY3457263 COMPARED TO PLACEBO IN PAR | 2025 | |
| 2025-01-31 | Eli Lilly Export S.A. Puerto Rico Branch | $465 | Research payment | In-kind items and services | A STUDY OF ORFORGLIPRON (LY3502970) IN PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH INSULIN GL | 2025 | |
| 2025-01-07 | Eli Lilly and Company | $2,729 | Research payment | Cash or cash equivalent | A STUDY OF ORFORGLIPRON (LY3502970) IN PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH INSULIN GL | 2025 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
In New York; placed by its state only.
| Measure | State New York |
|---|---|
| Population B01003 | 19,852,366 |
| Population, 2020 census P1 | 20,201,249 |
| Median age B01002 | 39.8 |
| Under 18 B01001 | 20.5% |
| 65 and over B01001 | 17.9% |
| Households B11001 | 7,722,646 |
| Foreign born B05002 | 22.8% |
| Median household income B19013 | $85,974 |
| Median family income B19113 | $106,873 |
| Per capita income B19301 | $50,712 |
| Poverty rate B17001 | 14.0% |
| Unemployment rate B23025 | 6.4% |
| Civilian labor force B23025 | 10,171,766 |
| Mean commute (minutes) B08013 | 32.6 |
| Bachelor's degree or higher B15003 | 40.2% |
| Housing units B25001 | 8,585,241 |
| Owner-occupied B25003 | 54.3% |
| Renters B25003 | 45.7% |
| Median home value B25077 | $423,800 |
| Median gross rent B25064 | $1,621 |
| White, not Hispanic B03002 | 52.8% |
| Black B03002 | 13.4% |
| Hispanic or Latino B03002 | 19.8% |
| Asian B03002 | 9.0% |
| American Indian and Alaska Native B03002 | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in New York.
Comments